Inhibition of Pgp expression may be related to celecoxib’s many off-target effects, such as inhibition of cancer-associated carbonic anhydrases [75], the master kinase PDK1 [76,77], or the sarco/endoplasmic reticulum Ca2+-ATPase [78]. Here, PDK1 is linked to cancer.